---
layout: post
title: "Patient Engagement in the Design and Conduct of Medical Device Clinical Studies; Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability"
date: 2026-02-05 18:57:50 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01374
original_published: 2022-01-26 00:00:00 +0000
significance: 8.00
---

# Patient Engagement in the Design and Conduct of Medical Device Clinical Studies; Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 26, 2022 00:00 UTC
**Document Number:** 2022-01374

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Patient Engagement in the Design and Conduct of Medical Device Clinical Studies." The Patient Engagement Advisory Committee (PEAC) recommended that FDA and industry develop a framework to clarify how patient advisors can engage in the clinical investigation process. This guidance focuses on the applications, perceived barriers, and common challenges of patient engagement in the design and conduct of medical device clinical studies.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/26/2022-01374/patient-engagement-in-the-design-and-conduct-of-medical-device-clinical-studies-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2022-01374

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
